Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesProperty, Plant & Equipment (Net)Retained EarningsSecuritiesSecurities - Held-to-maturitySecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShares OutstandingShort term DebtTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hanover Bancorp (HNVR) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Hanover Bancorp (HNVR) over the last 6 years, with Q3 2025 value amounting to $167.6 million.

  • Hanover Bancorp's Cash & Equivalents rose 1864.89% to $167.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $167.6 million, marking a year-over-year increase of 1864.89%. This contributed to the annual value of $162.9 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Hanover Bancorp reported Cash & Equivalents of $167.6 million as of Q3 2025, which was up 1864.89% from $164.5 million recorded in Q2 2025.
  • Hanover Bancorp's 5-year Cash & Equivalents high stood at $211.5 million for Q2 2023, and its period low was $77.5 million during Q1 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $160.2 million (2025), whereas its average is $155.4 million.
  • As far as peak fluctuations go, Hanover Bancorp's Cash & Equivalents skyrocketed by 10763.75% in 2021, and later plummeted by 3328.94% in 2024.
  • Hanover Bancorp's Cash & Equivalents (Quarter) stood at $115.0 million in 2021, then surged by 32.49% to $152.3 million in 2022, then rose by 16.36% to $177.2 million in 2023, then fell by 8.1% to $162.9 million in 2024, then increased by 2.89% to $167.6 million in 2025.
  • Its Cash & Equivalents stands at $167.6 million for Q3 2025, versus $164.5 million for Q2 2025 and $160.2 million for Q1 2025.